WHO Announces 2025 Flu Vaccine Update

The WHO recently recommended the 2025 influenza vaccine composition for the Southern Hemisphere. Compared to the 2024, the main change this year is the H3N2 component:

1. Egg-based vaccines: A/Croatia/10136RV/2023(H3N2)-like virus
2. Cell culture-, recombinant protein- or nucleic acid-based vaccines: A/District of Columbia/27/2023 (H3N2)-like a virus

Explore solutions to accelerate influenza vaccine development that are aligned with WHO’s latest recommendations!

Developing the Next Generation Herpes Virus Vaccines

The invasion of herpesviruses into host cells involves multiple glycoproteins such as gB,gC, gD,gH-gL, etc. The envelope glycoproteins of human herpesvirus are ideal targets for anti-viral drugs or vaccines that can stimulate the immune response.

ACROBiosystems Herpesvirus vaccines R&D solutions covered

• VZV
• HSV
• EBV
• CMV

Explore solutions for herpesvirus vaccine development to accelerate the next-generation herpes virus vaccine development!

Antigen-specific RSV reagents for Vaccine Development

Conformation-specific proteins are the key to unlocking effective RSV vaccines. Explore high-quality, structurally accurate proteins, antibodies, and kits to help you accelerate your RSV research!